Phil Gardella

Phil Gardella is a seasoned financial executive with extensive experience serving as a part-time or interim Chief Financial Officer for a variety of innovative companies across the life sciences, biotechnology, and technology sectors. Since 2007, Gardella has provided consulting CFO services at Port CFO Solutions, LLC, while holding prominent CFO roles at clinical-stage firms including Syntis Bio, Vizgen, and Sherlock Biosciences, focusing on advanced diagnostics and genomic profiling. Prior CFO positions at Ultivue, Arbor Biotechnologies, 908 Devices, Quanterix, Bluesocket, and PowerSteering Software highlight expertise in financial management, strategic planning, and operational improvements within both startup and established enterprises. Gardella holds an MBA in Finance from Babson College and a Bachelor's degree in Accounting from Northeastern University.